Thermo Fisher Scientific Inc. (TMO) stock
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 10/3030% above fair value
$692.74+5.95 (+0.87%)
Close on Nov 18, 2026Market cap $256.67BP/E 36.6Yield 0.25%
Thermo Fisher Scientific revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
Thermo Fisher Scientific's revenue for the twelve months ending Sep 26, 2026 was $47.35B, up 8.3% year over year. For fiscal 2025 it was $44.56B, up 3.9% from the year before. Over ten years it grew 10.1% a year on average. The highest annual figure on record is $44.92B in fiscal 2022.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $44.56B | +3.9% |
| FY2024 | Dec 31, 2024 | $42.88B | +0.1% |
| FY2023 | Dec 31, 2023 | $42.86B | -4.6% |
| FY2022 | Dec 31, 2022 | $44.92B | +14.5% |
| FY2021 | Dec 31, 2021 | $39.21B | +21.7% |
| FY2020 | Dec 31, 2020 | $32.22B | +26.1% |
| FY2019 | Dec 31, 2019 | $25.54B | +4.9% |
| FY2018 | Dec 31, 2018 | $24.36B | +16.4% |
| FY2017 | Dec 31, 2017 | $20.92B | +14.5% |
| FY2016 | Dec 31, 2016 | $18.27B | +7.7% |
| FY2015 | Dec 31, 2015 | $16.97B | +0.4% |
| FY2014 | Dec 31, 2014 | $16.89B | +29.0% |
| FY2013 | Dec 31, 2013 | $13.09B | +4.6% |
| FY2012 | Dec 31, 2012 | $12.51B | +8.2% |
| FY2011 | Dec 31, 2011 | $11.56B | +11.2% |
| FY2010 | Dec 31, 2010 | $10.39B | +4.9% |
| FY2009 | Dec 31, 2009 | $9.91B | -5.6% |
| FY2008 | Dec 31, 2008 | $10.50B | +7.7% |
| FY2007 | Dec 31, 2007 | $9.75B | – |
Quarterly revenue
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 26, 2026 | $12.14B | +9.1% |
| Q2 FY2026 | Jun 27, 2026 | $11.99B | +10.5% |
| Q1 FY2026 | Mar 28, 2026 | $11.01B | +6.2% |
| Q4 FY2025 | Dec 31, 2025 | $12.22B | +7.2% |
| Q3 FY2025 | Sep 27, 2025 | $11.12B | +4.9% |
| Q2 FY2025 | Jun 28, 2025 | $10.86B | +3.0% |
| Q1 FY2025 | Mar 29, 2025 | $10.36B | +0.2% |
| Q4 FY2024 | Dec 31, 2024 | $11.40B | +4.7% |
| Q3 FY2024 | Sep 28, 2024 | $10.60B | +0.2% |
| Q2 FY2024 | Jun 29, 2024 | $10.54B | -1.4% |
| Q1 FY2024 | Mar 30, 2024 | $10.35B | -3.4% |
| Q4 FY2023 | Dec 31, 2023 | $10.89B | -4.9% |
| Q3 FY2023 | Sep 30, 2023 | $10.57B | -1.0% |
| Q2 FY2023 | Jul 1, 2023 | $10.69B | -2.6% |
| Q1 FY2023 | Apr 1, 2023 | $10.71B | -9.4% |
| Q4 FY2022 | Dec 31, 2022 | $11.45B | +7.0% |
| Q3 FY2022 | Oct 1, 2022 | $10.68B | +14.4% |
| Q2 FY2022 | Jul 2, 2022 | $10.97B | +18.3% |
| Q1 FY2022 | Apr 2, 2022 | $11.82B | +19.3% |
| Q4 FY2021 | Dec 31, 2021 | $10.70B | +1.4% |
| Q3 FY2021 | Oct 2, 2021 | $9.33B | +9.5% |
| Q2 FY2021 | Jul 3, 2021 | $9.27B | +34.1% |
| Q1 FY2021 | Apr 3, 2021 | $9.91B | +59.0% |
| Q4 FY2020 | Dec 31, 2020 | $10.55B | +54.5% |
| Q3 FY2020 | Sep 26, 2020 | $8.52B | +35.9% |
| Q2 FY2020 | Jun 27, 2020 | $6.92B | +9.5% |
| Q1 FY2020 | Mar 28, 2020 | $6.23B | +1.7% |
| Q4 FY2019 | Dec 31, 2019 | $6.83B | +4.9% |
| Q3 FY2019 | Sep 28, 2019 | $6.27B | +5.9% |
| Q2 FY2019 | Jun 29, 2019 | $6.32B | +3.9% |
| Q1 FY2019 | Mar 30, 2019 | $6.13B | +4.6% |
| Q4 FY2018 | Dec 31, 2018 | $6.51B | +7.6% |
| Q3 FY2018 | Sep 29, 2018 | $5.92B | +15.7% |
| Q2 FY2018 | Jun 30, 2018 | $6.08B | +21.8% |
| Q1 FY2018 | Mar 31, 2018 | $5.85B | +22.8% |
| Q4 FY2017 | Dec 31, 2017 | $6.05B | +22.1% |
| Q3 FY2017 | Sep 30, 2017 | $5.12B | – |
| Q2 FY2017 | Jul 1, 2017 | $4.99B | – |
| Q1 FY2017 | Apr 1, 2017 | $4.77B | – |
| Q4 FY2016 | Dec 31, 2016 | $4.95B | – |
See a number that looks wrong?